Long-term follow-up of the thyroid gland after treatment with 131 I-Metaiodobenzylguanidine in children with neuroblastoma: Importance of continuous surveillance-Reference-Cited by-同舟云学术

Long-term follow-up of the thyroid gland after treatment with 131 I-Metaiodobenzylguanidine in children with neuroblastoma: Importance of continuous surveillance

Published:2013-07-06 Issue:11 Volume:60 Page:1833-1838
ISSN:1545-5009
Container-title:Pediatric Blood & Cancer
language:en
Short-container-title:Pediatr Blood Cancer

Author:

Clement S.C.¹,van Eck-Smit B.L.F.²,van Trotsenburg A.S.P.¹,Kremer L.C.M.³,Tytgat G.A.M.³,van Santen H.M.¹

Affiliation:

1. Department of Pediatric Endocrinology; Emma Children's Hospital, Academic Medical Center, University of Amsterdam; Amsterdam The Netherlands

2. Department of Nuclear Medicine; Academic Medical Center, University of Amsterdam; Amsterdam The Netherlands

3. Department of Pediatric Oncology; Emma Children's Hospital, Academic Medical Center, University of Amsterdam; Amsterdam The Netherlands

Publisher

Wiley

Subject

Oncology,Hematology,Pediatrics, Perinatology, and Child Health

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/pbc.24681/fullpdf

Reference25 articles.

1. Radiolabeled metaiodobenzylguanidine for imaging and therapy of neuroblastoma;Taggart;Q J Nucl Med Mol Imaging,2008

2. Iodine-131-metaiodobenzylguanidine as initial induction therapy in stage 4 neuroblastoma patients over 1 year of age;de Kraker;Eur J Cancer,2008

3. [131I] metaiodobenzylguanidine therapy after conventional therapy for neuroblastoma;Hoefnagel;J Nucl Biol Med,1991

4. 131I-MIBG as a first-line treatment in high-risk neuroblastoma patients;Hoefnagel;Nucl Med Commun,1994

5. [131I] MIBG as a first line treatment in advanced neuroblastoma;Hoefnagel;Q J Nucl Med,1995

Cited by 49 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A narrative review of 35 years of meta-[131I]iodobenzylguanidine therapy in neuroblastoma;EJC Paediatric Oncology;2024-06

2. Incidence of subclinical and overt hypothyroidism in children treated with [131I]mIBG: a systematic review and meta-analysis;The Quarterly Journal of Nuclear Medicine and Molecular Imaging;2024-04

3. Impact of risk-based therapy on late morbidity and mortality in neuroblastoma survivors: a report from the Childhood Cancer Survivor Study;JNCI: Journal of the National Cancer Institute;2024-03-09

4. Timing and chemotherapy association for 131-I-MIBG treatment in high-risk neuroblastoma;Biochemical Pharmacology;2023-10

5. Thyroid dysfunction during treatment with systemic antineoplastic therapy for childhood cancer: A systematic review;Critical Reviews in Oncology/Hematology;2023-04